College of American Pathologists

Boston IVF Fertility Network Recognized Among Newsweek Magazine's America's Best Fertility Clinics of 2024

Retrieved on: 
목요일, 4월 25, 2024
Statista, Fertility, Hope, Infertility, Statistics, Male, Research, College of American Pathologists, IVF, Joint Commission, American Institute, Nursing, Accreditation, Patient, Physician, IUI

WALTHAM, Mass., April 25, 2024 /PRNewswire-PRWeb/ -- Boston IVF, a world leader in fertility care, announced today that four of its centers across New England and the Midwest have been recognized on Newsweek's 2024 list of America's Best Fertility Clinics.

Key Points: 
  • Boston IVF's fertility center in Bedford, NH
    "This prestigious acknowledgment stands as a tribute to the devotion of our physicians, nurses, clinical team, embryologists, researchers, and staff, who all tirelessly strive to bring hope and joy to the lives of our patients," said Boston IVF CEO David Stern.
  • As part of the America's Best Fertility Clinics evaluation, each fertility clinic was analyzed and scored on four data points, including a nationwide online survey of fertility clinic employees, quality metrics for assisted reproductive technology, accreditation data from The Joint Commission, College of American Pathologists, Clinical Laboratory Improvement Amendments, and American Institute of Ultrasound in Medicine, and patient satisfaction data.
  • Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners.
  • Boston IVF offers a full array of innovative reproductive treatments and services, including intrauterine insemination (IUI ), in vitro fertilization (IVF), preimplantation genetic screening , male infertility testing , egg freezing , LGBTQ+ family building , and more.

Medicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer

Retrieved on: 
화요일, 10월 10, 2023
College, Flagship Pioneering, Harbor, Therapy, Roivant Sciences, University, Novartis, Cancer, Memorial University of Newfoundland, AstraZeneca, MDNA, MIT, CMO, Harvard Medical School, Publication, College of American Pathologists, Science, Assistant, Scripps Research, Whitehead Institute, Glioblastoma, Translational medicine, Memorial University of Newfoundland Faculty of Medicine, Pharmaceutical industry, Biochemistry, Oncology, Biogen

TORONTO and HOUSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA TSX: MDNA), a clinical-stage immunotherapy company focused on the development of novel Superkines, today announced the appointment of Humphrey Gardner, M.D., as Chief Medical Officer (CMO) to lead the development strategy and execution of Medicenna’s clinical programs.

Key Points: 
  • TORONTO and HOUSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA TSX: MDNA), a clinical-stage immunotherapy company focused on the development of novel Superkines, today announced the appointment of Humphrey Gardner, M.D., as Chief Medical Officer (CMO) to lead the development strategy and execution of Medicenna’s clinical programs.
  • Dr. Gardner holds remarkable leadership experiences advancing immune-based therapies for cancer and other diseases from the earliest stages of development through regulatory approvals,” said Fahar Merchant, Ph.D., President and Chief Executive Officer of Medicenna.
  • Previously, he was the CMO at Stingthera, CMO in Residence at Roivant Sciences and Chief of Medical Oncology at Evelo Biosciences, a Flagship Pioneering company.
  • Dr. Gardner holds a bachelor’s degree in Biochemistry and his medical degree from the University of Cambridge.

College of American Pathologists Partners with Homethrive to Offer Caregiving Benefit

Retrieved on: 
월요일, 10월 16, 2023
Men, Health, Family, Human Resources, Consumer, Other Health, Professional Services, People with Disabilities, DEI (Diversity, Equity and Inclusion), Parenting, General Health, LGBTQ+, Women, Seniors, Parkinson's disease, College of American Pathologists, Parent, Doctor of Philosophy, Asian Americans, Organization, FMLA, Caregiver, Dementia, CAP, LGBTQ, Ageing, Policy, Grandparent, Disability, Woman, Residential care

That’s why the College of American Pathologists (CAP), the leading organization of board-certified pathologists, has partnered with Homethrive to offer its intuitive caregiving platform to any of their employees who care for a loved one due to age, disability, or a medical condition.

Key Points: 
  • That’s why the College of American Pathologists (CAP), the leading organization of board-certified pathologists, has partnered with Homethrive to offer its intuitive caregiving platform to any of their employees who care for a loved one due to age, disability, or a medical condition.
  • They do the legwork, making calls, and following up on care plans for people who are balancing work and family responsibilities.
  • [We had] people who were in crisis.”
    Caregiving benefits like Homethrive support the diversity, equity, and inclusion goals of organizations like the CAP.
  • Homethrive also supports the unique caregiving needs of the LGBTQ community and is available to work with employee resource groups to help caregivers connect, share experiences, and find support.

College of American Pathologists Honors 29 Members/Residents at CAP23 Annual Meeting

Retrieved on: 
토요일, 10월 7, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Medical Devices, Virginia House of Delegates, College, Consultant (medicine), Clinical, Accreditation, Illinois Department of Veterans' Affairs, Human services, CAP, Engineer Research and Development Center, Council, Marie Cassidy, Education, Member, College of American Pathologists, Pathology, Illinois Department of Human Services, HOD, House, National Council for Accreditation of Teacher Education, Patient, Property management, Nursing, MD, Southern Illinois University

The College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists and the leading provider of laboratory accreditation and proficiency testing programs, honored several of its members for their contributions to pathology and laboratory medicine during its annual meeting, in Chicago, Illinois October 7-10, 2023.

Key Points: 
  • The College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists and the leading provider of laboratory accreditation and proficiency testing programs, honored several of its members for their contributions to pathology and laboratory medicine during its annual meeting, in Chicago, Illinois October 7-10, 2023.
  • In recognition of her long and distinguished career in pathology, the CAP named Bharati Suketu Jhaveri, MD, FCAP, Pathologist of the Year.
  • Dr. Jhaveri has devoted much of her professional life to the CAP.
  • “I am grateful to be recognized for this prestigious award from the College of American Pathologists and consider this award encouragement to continue,” shares Dr. Jhaveri.

Laboratory Proficiency Testing Market worth $1.6 billion | MarketsandMarkets

Retrieved on: 
수요일, 10월 4, 2023
Emerald, Public, Food safety, Chromatography, Lung compliance, Merck Group, AOAC, Incidence, Randox, Risk, Waters Corporation, Laboratory, University, College of American Pathologists, Food Animal Concerns Trust, Bio-Rad Laboratories, Culture, Mpox, Cosmetics, Research, Environmental monitoring, Growth, PCR, Microbiology, Safety, Government, American Industrial Hygiene Association, Dietary supplement, Fera Science, Water, Quality assurance, Spectrophotometry, Ortho Clinical Diagnostics, Partnership, College, Sartorius AG, Food quality, Education, Communities and Justice Directorates, SPEX, Medical device, Fine chemical, Airline

In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.

Key Points: 
  • In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.
  • In 2022, the cell culture segment held the largest market share in the Laboratory Proficiency Testing market.
  • The APAC Laboratory Proficiency Testing market is projected to grow at the highest rate during the forecast period.
  • The laboratory proficiency testing market is segmented into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Laboratory Proficiency Testing Market worth $1.6 billion | MarketsandMarkets

Retrieved on: 
수요일, 10월 4, 2023
Emerald, Public, Food safety, Chromatography, Lung compliance, Merck Group, AOAC, Incidence, Randox, Risk, Waters Corporation, Laboratory, University, College of American Pathologists, Food Animal Concerns Trust, Bio-Rad Laboratories, Culture, Mpox, Cosmetics, Research, Environmental monitoring, Growth, PCR, Microbiology, Safety, Government, American Industrial Hygiene Association, Dietary supplement, Fera Science, Water, Quality assurance, Spectrophotometry, Ortho Clinical Diagnostics, Partnership, College, Sartorius AG, Food quality, Education, Communities and Justice Directorates, SPEX, Medical device, Fine chemical, Airline

In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.

Key Points: 
  • In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market.
  • In 2022, the cell culture segment held the largest market share in the Laboratory Proficiency Testing market.
  • The APAC Laboratory Proficiency Testing market is projected to grow at the highest rate during the forecast period.
  • The laboratory proficiency testing market is segmented into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

Retrieved on: 
화요일, 9월 19, 2023
Biotechnology, FDA, Other Health, Health, Radiology, Pharmaceutical, Oncology, Medical Devices, Surgery, Genetics, Clinical Trials, COPD, DNA, Fitzsimons Army Medical Center, American Board of Psychiatry and Neurology, College, Internal medicine, Louisiana State University, Marketing, Clinical Laboratory, SARS-CoV-2, CAP, Marie Cassidy, Pathology, Lung cancer, Lead, American Academy, College of American Pathologists, BIAF, Brooke Army Medical Center, Lung, Sale, Organization, American Board of Commissioners for Foreign Missions, STI, CLIA, Acquisition, Physician, Trustee, Psychiatry, American Academy of Neurology, Maria, American Board of Pathology, Medical imaging, Nursing, Neurology

bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of Village Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.

Key Points: 
  • bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of Village Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
  • The laboratory assets are being acquired by a new wholly owned subsidiary of bioAffinity Technologies, Precision Pathology Laboratory Services, LLC (PPLS).
  • Precision Pathology provides pathology services to physicians practicing in a variety of outpatient settings and has offered bioAffinity Technologies’ CyPath® Lung as a laboratory developed test for the detection of early-stage lung cancer.
  • In addition to CyPath® Lung, Precision Pathology offers a range of laboratory services including respiratory testing for SARS-CoV-2 and influenza, anatomic pathology, morphological stains, histological services, DNA extractions, STI testing, and women’s and men’s health testing.

American Oncology Network Names Dr. Ryan Olson as Medical Director of the In-House Pathology Laboratory

Retrieved on: 
수요일, 7월 5, 2023
Histology, Six Sigma, University, College, AON, Lean, Pathology, College of American Pathologists, University of California, San Diego Performance-Based Skills Assessment, AMC, Certification, Albany Medical College, Patient, Physician, Investment, Flow cytometry, Cytogenetics, Health, Nursing, Medical imaging, MD

FORT MYERS, Fla., July 05, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), one of the nation’s fastest growing networks of community oncology practices, is pleased to announce Ryan Olson, MD , has joined as the new medical director of AON’s pathology laboratory , effective June 26.

Key Points: 
  • FORT MYERS, Fla., July 05, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), one of the nation’s fastest growing networks of community oncology practices, is pleased to announce Ryan Olson, MD , has joined as the new medical director of AON’s pathology laboratory , effective June 26.
  • Dr. Olson received his medical degree from Albany Medical College (AMC) in Albany, New York, and completed a residency at the University of California San Diego and AMC.
  • Dr. Olson is Board-certified in anatomic pathology, clinical pathology and hematopathology.
  • "I look forward to joining AON and helping to drive more improved health outcomes via the pathology lab,” said Dr. Olson.

LetsGetChecked Names Avni Santani, PhD, FACMG, Chief Genomics Officer Following Acquisition of Veritas Genetics

Retrieved on: 
수요일, 6월 21, 2023
General Health, Health, Health Technology, Telemedicine, Virtual Medicine, Health Insurance, Informatics, American Society for Clinical Laboratory Science, University, College, CHOP, Texas A&M University, College of American Pathologists, Multimedia, Associate, Public sector, Organization, American Board of Commissioners for Foreign Missions, Pathology, FACMG, AI, Association for Molecular Pathology v. Myriad Genetics, Inc., Veritas Genetics, Medical genetics, Antibiotics, Genomics, Doctor of Philosophy, Genetics

LetsGetChecked, a global healthcare solutions company, announced today the appointment of Avni Santani, PhD, FACMG, to Chief Genomics Officer.

Key Points: 
  • LetsGetChecked, a global healthcare solutions company, announced today the appointment of Avni Santani, PhD, FACMG, to Chief Genomics Officer.
  • She joins the team from Veritas Genetics, a pioneering genomics company that was acquired by LetsGetChecked in 2022.
  • Dr. Santani holds a Ph.D. in Genetics from Texas A&M University and is board-certified in clinical laboratory genetics and genomics by the American Board of Medical Genetics and Genomics (ABMGG).
  • “I am delighted to be continuing my work in genetics with LetsGetChecked,” said Dr. Avni Santani, Chief Genomics Officer at LetsGetChecked.

CND Life Sciences Receives Accreditation from the College of American Pathologists

Retrieved on: 
금요일, 6월 16, 2023
CND, Accreditation, College, CAP, Record, DSM-IV codes, College of American Pathologists, Medical director, MD, Laboratory, Patient, Health, Nursing, Medical device

SCOTTSDALE, Ariz., June 16, 2023 /PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of skin-based tests to help clinicians diagnose neurodegenerative diseases and other neurologic disorders, has been awarded accreditation by the College of American Pathologists (CAP).

Key Points: 
  • SCOTTSDALE, Ariz., June 16, 2023 /PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of skin-based tests to help clinicians diagnose neurodegenerative diseases and other neurologic disorders, has been awarded accreditation by the College of American Pathologists (CAP).
  • Recognized for rigorous and robust standards, CAP accreditation elevates quality in important ways so that laboratories can contribute to improved patient outcomes.
  • "We are proud to attain accreditation from the College of American Pathologists and look forward to driving continuous quality programs well into the future."
  • "Accreditation by the College of American Pathologists is an important milestone for CND," said Theresa Rosov, CND's Senior Quality Manager.